BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 7475281)

  • 21. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
    Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
    Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome.
    Schlesinger M; Silverman LR; Jiang JD; Yagi MJ; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1996; 48(4):149-66. PubMed ID: 9819667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Flow cytometric characterization of maturation processes and primitive stem cell population in pre-B-cell ALL in childhood].
    Baersch G; Baumann M; Meltzer J; Möllers T; Ritter J; Jürgens H; Vormoor J
    Klin Padiatr; 1996; 208(4):160-7. PubMed ID: 8926682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunophenotype of c-kit cells in normal human bone marrow: implications for the detection of minimal residual disease in AML.
    Macedo A; Orfao A; Martínez A; Vidriales MB; Valverde B; López-Berges MC; San Miguel JF
    Br J Haematol; 1995 Feb; 89(2):338-41. PubMed ID: 7532985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic differences of CD34-positive stem cells harvested from peripheral blood and bone marrow obtained before and after peripheral blood stem cell collection.
    Inaba T; Shimazaki C; Hirata T; Ashihara E; Okawa K; Oku N; Goto H; Fujita N; Tsuji H; Nakagawa M
    Bone Marrow Transplant; 1994 May; 13(5):527-32. PubMed ID: 7519935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors.
    Matarraz S; López A; Barrena S; Fernandez C; Jensen E; Flores J; Bárcena P; Rasillo A; Sayagues JM; Sánchez ML; Hernandez-Campo P; Hernandez Rivas JM; Salvador C; Fernandez-Mosteirín N; Giralt M; Perdiguer L; Orfao A
    Leukemia; 2008 Jun; 22(6):1175-83. PubMed ID: 18337765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative multi-color flow cytometric analysis of cell surface antigens in bone marrow hematopoietic progenitors between refractory anemia and aplastic anemia.
    Otawa M; Kawanishi Y; Iwase O; Shoji N; Miyazawa K; Ohyashiki K
    Leuk Res; 2000 Apr; 24(4):359-66. PubMed ID: 10713334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triple immunofluorescence evaluation of CD15, CD34 and class II expression by flow cytometry in normal and leukemic bone marrows.
    Venditti A; Del Poeta G; Stasi R; De Fabriitis P; Coppetelli U; Bruno A; Simone MD; Papa G
    Haematologica; 1993; 78(6):359-63. PubMed ID: 7513673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
    Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF
    Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shifts.
    van Lochem EG; van der Velden VH; Wind HK; te Marvelde JG; Westerdaal NA; van Dongen JJ
    Cytometry B Clin Cytom; 2004 Jul; 60(1):1-13. PubMed ID: 15221864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lineage commitment of CD34+ human hematopoietic progenitor cells.
    Tjønnfjord GE; Steen R; Veiby OP; Egeland T
    Exp Hematol; 1996 Jul; 24(8):875-82. PubMed ID: 8690045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells.
    Hurwitz CA; Gore SD; Stone KD; Civin CI
    Leukemia; 1992 Apr; 6(4):233-9. PubMed ID: 1375301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD34 progenitor cell subset analyses in normal human bone marrow and marrow harvested after intermediate-dose chemotherapy.
    Laughlin MJ; Christiansen NP; Herzig GP; Blumenson L; Bonney D; Stewart CC
    Cytometry; 1996 Dec; 26(4):235-42. PubMed ID: 8979021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-CAM (CD56) expression by CD34+ malignant myeloblasts has implications for minimal residual disease detection in acute myeloid leukemia.
    Coustan-Smith E; Behm FG; Hurwitz CA; Rivera GK; Campana D
    Leukemia; 1993 Jun; 7(6):853-8. PubMed ID: 7684798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of CD34-positive cells and subpopulations in human umbilical cord blood and bone marrow.
    Kinniburgh D; Russell NH
    Bone Marrow Transplant; 1993 Nov; 12(5):489-94. PubMed ID: 7507766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
    Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation.
    Lucio P; Gaipa G; van Lochem EG; van Wering ER; Porwit-MacDonald A; Faria T; Bjorklund E; Biondi A; van den Beemd MW; Baars E; Vidriales B; Parreira A; van Dongen JJ; San Miguel JF; Orfao A;
    Leukemia; 2001 Aug; 15(8):1185-92. PubMed ID: 11480560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic quantitative features of patients with acute myeloid leukemia.
    Pereira FG; Metze K; Costa FP; Lima CS; Lorand-Metze I
    Neoplasma; 2006; 53(2):155-60. PubMed ID: 16575472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver.
    Roy V; Miller JS; Verfaillie CM
    Exp Hematol; 1997 May; 25(5):387-94. PubMed ID: 9168060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotype analysis of hematopoietic CD34+ cell populations derived from human umbilical cord blood using flow cytometry and cDNA-polymerase chain reaction.
    Thoma SJ; Lamping CP; Ziegler BL
    Blood; 1994 Apr; 83(8):2103-14. PubMed ID: 7512840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.